- Home
- IMCC vs ALBT Comparison
IMCC vs ALBT Comparison
Compare IMCC & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- ALBT
- Stock Information
- Founded
- IMCC 1980
- ALBT 2014
- Country
- IMCC Israel
- ALBT United States
- Employees
- IMCC N/A
- ALBT N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMCC Health Care
- ALBT Health Care
- Exchange
- IMCC Nasdaq
- ALBT Nasdaq
- Market Cap
- IMCC 5.0M
- ALBT 2.9M
- IPO Year
- IMCC N/A
- ALBT N/A
- Fundamental
- Price
- IMCC $2.23
- ALBT $0.20
- Analyst Decision
- IMCC
- ALBT
- Analyst Count
- IMCC 0
- ALBT 0
- Target Price
- IMCC N/A
- ALBT N/A
- AVG Volume (30 Days)
- IMCC 11.8K
- ALBT 639.6K
- Earning Date
- IMCC 11-11-2024
- ALBT 11-12-2024
- Dividend Yield
- IMCC N/A
- ALBT N/A
- EPS Growth
- IMCC N/A
- ALBT N/A
- EPS
- IMCC N/A
- ALBT N/A
- Revenue
- IMCC $36,445,402.00
- ALBT N/A
- Revenue This Year
- IMCC $22.59
- ALBT N/A
- Revenue Next Year
- IMCC $20.53
- ALBT N/A
- P/E Ratio
- IMCC N/A
- ALBT N/A
- Revenue Growth
- IMCC N/A
- ALBT N/A
- 52 Week Low
- IMCC $1.13
- ALBT $0.16
- 52 Week High
- IMCC $8.10
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- IMCC 41.06
- ALBT 42.61
- Support Level
- IMCC $2.02
- ALBT $0.16
- Resistance Level
- IMCC $2.15
- ALBT $0.30
- Average True Range (ATR)
- IMCC 0.14
- ALBT 0.03
- MACD
- IMCC -0.01
- ALBT 0.00
- Stochastic Oscillator
- IMCC 19.15
- ALBT 26.09
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.